Business Description
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
ISIN : CNE100004090
Share Class Description:
SHSE:603392: Class ACompare
Compare
Traded in other countries / regions
603392.China IPO Date
2020-04-29Description
Beijing Wantai Biological Pharmacy Enterprise Co Ltd is engaged in Research, development, production and sales of in vitro diagnostic reagents, instruments and vaccines.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 20.07 | |||||
| Equity-to-Asset | 0.84 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.93 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 29.3 | |||||
| Beneish M-Score | -2.41 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 30.4 | |||||
| 3-Year EBITDA Growth Rate | 22.1 | |||||
| 3-Year EPS without NRI Growth Rate | 18 | |||||
| 3-Year FCF Growth Rate | 66.5 | |||||
| 3-Year Book Growth Rate | 69.1 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 93.72 | |||||
| 9-Day RSI | 86.83 | |||||
| 14-Day RSI | 80.2 | |||||
| 6-1 Month Momentum % | 2.42 | |||||
| 12-1 Month Momentum % | 42.71 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.48 | |||||
| Quick Ratio | 4.08 | |||||
| Cash Ratio | 2.52 | |||||
| Days Inventory | 465.18 | |||||
| Days Sales Outstanding | 459.32 | |||||
| Days Payable | 174.84 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.41 | |||||
| Dividend Payout Ratio | 2.21 | |||||
| Forward Dividend Yield % | 0.41 | |||||
| 5-Year Yield-on-Cost % | 0.38 | |||||
| 3-Year Average Share Buyback Ratio | -1 | |||||
| Shareholder Yield % | 0.34 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 72.26 | |||||
| Operating Margin % | -3.35 | |||||
| Net Margin % | -7.16 | |||||
| FCF Margin % | 18.13 | |||||
| ROE % | -1.5 | |||||
| ROA % | -1.23 | |||||
| ROIC % | -0.82 | |||||
| ROC (Joel Greenblatt) % | -5.46 | |||||
| ROCE % | -2.08 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 122.67 | |||||
| PE Ratio without NRI | 546.55 | |||||
| Shiller PE Ratio | 97.84 | |||||
| PEG Ratio | 9.33 | |||||
| PS Ratio | 36.4 | |||||
| PB Ratio | 8.01 | |||||
| Price-to-Tangible-Book | 8.47 | |||||
| Price-to-Free-Cash-Flow | 202.16 | |||||
| Price-to-Operating-Cash-Flow | 65.99 | |||||
| EV-to-EBIT | -363.06 | |||||
| EV-to-EBITDA | -363.06 | |||||
| EV-to-Revenue | 37.06 | |||||
| EV-to-FCF | 200.54 | |||||
| Price-to-Projected-FCF | 5.97 | |||||
| Price-to-DCF (Earnings Based) | 15.88 | |||||
| Price-to-DCF (FCF Based) | 5.87 | |||||
| Price-to-Graham-Number | 14.36 | |||||
| Price-to-Net-Current-Asset-Value | 14.81 | |||||
| Price-to-Net-Cash | 36.52 | |||||
| Earnings Yield (Greenblatt) % | -0.28 | |||||
| FCF Yield % | 0.49 | |||||
| Forward Rate of Return (Yacktman) % | 20.8 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 2,713.187 | ||
| EPS (TTM) (Â¥) | -0.14 | ||
| Beta | 1.51 | ||
| Volatility % | 74.21 | ||
| 14-Day RSI | 80.2 | ||
| 14-Day ATR (Â¥) | 2.903826 | ||
| 20-Day SMA (Â¥) | 71.064 | ||
| 12-1 Month Momentum % | 42.71 | ||
| 52-Week Range (Â¥) | 40.14 - 89.89 | ||
| Shares Outstanding (Mil) | 1,265.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Frequently Asked Questions
What is Beijing Wantai Biological Pharmacy Enterprise Co Ltd(SHSE:603392)'s stock price today?
The current price of SHSE:603392 is ¥79.25. The 52 week high of SHSE:603392 is ¥89.89 and 52 week low is ¥40.14.
When is next earnings date of Beijing Wantai Biological Pharmacy Enterprise Co Ltd(SHSE:603392)?
The next earnings date of Beijing Wantai Biological Pharmacy Enterprise Co Ltd(SHSE:603392) is .
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd(SHSE:603392) pay dividends? If so, how much?
The Dividend Yield %  of Beijing Wantai Biological Pharmacy Enterprise Co Ltd(SHSE:603392) is 0.41% (As of Today), Highest Dividend Payout Ratio of Beijing Wantai Biological Pharmacy Enterprise Co Ltd(SHSE:603392) was 2.21. The lowest was 0.04. And the median was 0.06. The  Forward Dividend Yield % of Beijing Wantai Biological Pharmacy Enterprise Co Ltd(SHSE:603392) is 0.41%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers